Table 2.
VARIABLE | COMPARISON | p-value | ||
---|---|---|---|---|
n | PFS | OS | ||
Vitreous seeds | Presence vs. absence of vitreous seeds | 29 | 0.35 | 0.03 |
Prior treatment status | Prior treated vs naïve | 29 | 0.40 | 0.86 |
Latency of relapse | Interval btwn initial OAC end & relapse <4.4mos vs >=4.4mos | 29 | 0.22 | 0.34 |
Age at initial OAC | Age <1yr or <= 1 yr during initial OAC | 29 | 0.45 | 0.15 |
No. of initial infusions | <3 infusions vs >= 3 infusions during initial OAC | 29 | 0.56 | 0.23 |
Addition of new drug | Absence vs addition of new drug during 2nd course | 29 | 0.93 | 0.23 |
No. of 2nd infusions | 1 vs >1 infusion during 2nd course | 29 | 0.37 | 1.00 |
Max melphalan | Max melphalan <5mg vs >= 5mg during 2nd course | 29 | 0.86 | 0.49 |
Max melphalan/Kg | Max melphalan/Kg <0.4mg/Kg vs >=0.4mg/Kg during 2nd course | 29 | 0.43 | 0.66 |
Cumltv melphalan | Cumltv melphalan <8mg vs >= 8mg during 2nd course | 29 | 0.56 | 0.21 |
Cumltv melphalan/Kg | Cumltv melphalan/Kg <0.6mg/Kg vs >= 0.6mg/Kg during 2nd course | 29 | 0.83 | 0.50 |
Increasing max melphalan | Increasing vs decreasing max melphalan during 2nd course | 28 | 0.88 | 0.63 |
Increasing max melphalan/Kg | Increasing vs decreasing max melphalan/Kg during 2nd course | 28 | 0.22 | 0.13 |
Increasing max topotecan/Kg | Increasing vs decreasing max topotecan/Kg during 2nd course | 20 | 0.04 | 0.28 |
Increasing max carboplatin/Kg | Increasing vs decreasing max carboplatin/Kg during 2nd course | 12 | 0.42 | 1.00 |
Increasing max dose any drug | Increasing vs decreasing max dose any drug during 2nd course | 29 | 0.67 | 0.75 |
Increasing max dose/Kg any drug | Increasing vs decreasing max dose/Kg any drug during 2nd course | 29 | 0.07 | 0.75 |
Increasing cumltv melphalan | Increasing vs decreasing cumltv melphalan during 2nd course | 29 | 0.85 | 0.40 |
Increasing cumltv melphalan/Kg | Increasing vs decreasing cumltv melphalan/Kg during 2nd course | 29 | 0.39 | 0.83 |
Increasing cumltv topotecan/Kg | Increasing vs decreasing cumltv topotecan/Kg during 2nd course | 19 | 0.09 | 0.25 |
Increasing cumltv carboplatin/Kg | Increasing vs decreasing cumltv carboplatin/Kg during 2nd course | 12 | 0.99 | 1.00 |
Increasing cumltv any drug | Increasing vs decreasing cumltv dose any drug during 2nd course | 29 | 0.86 | 0.45 |
Increasing cumtv dose/Kg any drug | Increasing vs decreasing cumtv dose/Kg any drug during 2nd course | 29 | 0.14 | 0.62 |
Increasing max dose/Kg any drug/new drug | Increasing max dose/Kg any drug or new drug vs. not during 2nd course | 29 | 0.24 | 0.79 |
PFS= progression free survival, OS = ocular survival, cumtv= cumulative, max= maximum, OAC = ophthalmic artery chemosurgery, yr = year, no. = number, vs = versus, cumltv = cumulative, btwn = between, mos= months